Rochester, NY 7/11/2009 12:26:11 AM
Afternoon Stocks - PFE - Pfizer plans to appeal Canada ruling on Norvasc
Pfizer Inc.,PFE
Afternoon Stocks - PFE - Pfizer plans to appeal Canada ruling on Norvasc
---
Pfizer Inc.,PFE
Last Trade: 14.27
Day's Range: 14.11 - 14.29
52wk Range: 11.62 - 20.13
Volume: 21,526,927
COMPANY "In The News"
Pfizer Inc. said Thursday a Canadian appeals court voided a patent protecting its blood pressure drug Norvasc, and said it plans to appeal the ruling. The New York drugmaker said the Canadian Federal Court declared the patent invalid. Pfizer said it is disappointed and will file an appeal to the Federal Court of Appeal of Canada. The challenge was brought by Ratiopharm, and covers the active ingredient in the drug, amlodipine besylate.
COMPANY DETAILS
Pfizer Inc. engages in the discovery, development, manufacture, and marketing of prescription medicines for humans and animals worldwide. Its Pharmaceutical segment offers Lipitor for elevated cholesterol levels in the blood; Norvasc for hypertension; Caduet for cardiovascular events; Chantix/Champix for smoking cessation; Lyrica for neuropathic pain; Geodon/Zeldox, a psychotropic agent; and Aricept for Alzheimer's disease.
---
At WhisperfromWallStreet.com we specialize in understand the markets, particularly the penny stock market and understand what makes penny stocks increase. In a word it is exposure and by that we mean making the investing public aware of a particular stock, via an investor awareness campaign. Our tracking is second to none with our alerts in 2009 producing an average price gain of 80%+. If you'd like to track our results or receive your own alerts based on our experience, sign up now at... WhisperfromWallStreet.com
---
It's important that every investor be aware of our disclaimer which can be read in its entirety :
http://whisperfromwallstreet.com/disclaimer.php
IMPORTANT NOTE: This is not a solicitation to buy or sell any securities. WhisperfromWallStreet.com, nor any of its affiliates are not registered investment advisors or a broker dealers. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.
